Cystic Fibrosis

(asked on 25th July 2019) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect on the availability of treatments and medication for cystic fibrosis of the UK leaving the EU without a deal.


Answered by
Chris Skidmore Portrait
Chris Skidmore
This question was answered on 9th September 2019

As part of a responsible Government, the Department is doing everything appropriate to prepare for European Union exit. We want to reassure patients that our plans should ensure the supply of medicines and medical products remains uninterrupted when we leave the European Union on 31 October.

The Department, in consultation with the devolved administrations, has been working with trade bodies, product suppliers, and the health and care system in England to make detailed plans that should ensure continuation of the supply of medicines, including those for people with cystic fibrosis, to the whole of the United Kingdom and its Crown Dependencies.

On 26 June, we wrote to suppliers of medicines to the UK from or via the EU or European Economic Area setting out our continuing multi-layered approach to support continuity of supply of medicines and medical products in a potential ‘no deal’ exit scenario on 31 October.

Further details can be found at the following link:

https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans

Reticulating Splines